CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860103. A total of 25 filers reported holding CLEVELAND BIOLABS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $1,000 | 0.0% | 164 | -95.3% | 0.00% | – |
Q4 2014 | $1,000 | -66.7% | 3,476 | -45.7% | 0.00% | – |
Q3 2014 | $3,000 | +50.0% | 6,399 | +45.5% | 0.00% | – |
Q2 2014 | $2,000 | -33.3% | 4,399 | +12.8% | 0.00% | – |
Q1 2014 | $3,000 | -50.0% | 3,899 | -20.4% | 0.00% | – |
Q4 2013 | $6,000 | +20.0% | 4,899 | +46.9% | 0.00% | – |
Q3 2013 | $5,000 | -86.1% | 3,336 | -85.5% | 0.00% | -100.0% |
Q2 2013 | $36,000 | – | 23,004 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 1,826,158 | $1,244,000 | 0.07% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 721,200 | $507,000 | 0.02% |
Winfield Associates, Inc. | 15,711 | $11,000 | 0.01% |
Van Cleef Asset Management,Inc | 20,000 | $14,000 | 0.01% |
ACG Wealth | 25,000 | $17,000 | 0.01% |
TAURUS ASSET MANAGEMENT, LLC | 15,000 | $10,000 | 0.00% |
OPPENHEIMER & CO INC | 25,500 | $17,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 3,000 | $2,000 | 0.00% |
NORTHERN TRUST CORP | 72,158 | $49,000 | 0.00% |
AMERIPRISE FINANCIAL INC | 50 | $0 | 0.00% |